nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—CYP17A1—prostate cancer	0.0344	0.132	CbGaD
Progesterone—SLC22A3—prostate cancer	0.0328	0.126	CbGaD
Progesterone—Nandrolone phenpropionate—Estradiol valerate/Dienogest—prostate cancer	0.0281	0.114	CrCrCtD
Progesterone—Nandrolone decanoate—Estradiol valerate/Dienogest—prostate cancer	0.0281	0.114	CrCrCtD
Progesterone—SHBG—prostate cancer	0.0239	0.0913	CbGaD
Progesterone—CYP1B1—prostate cancer	0.0239	0.0913	CbGaD
Progesterone—SLC22A1—prostate cancer	0.0235	0.0902	CbGaD
Progesterone—Testosterone—Abiraterone—prostate cancer	0.0234	0.0949	CrCrCtD
Progesterone—CYP17A1—Abiraterone—prostate cancer	0.0216	0.0697	CbGbCtD
Progesterone—AR—prostate cancer	0.0209	0.0801	CbGaD
Progesterone—Trilostane—Estradiol—prostate cancer	0.0199	0.0808	CrCrCtD
Progesterone—CYP3A5—prostate cancer	0.019	0.0727	CbGaD
Progesterone—CYP2A6—prostate cancer	0.0184	0.0704	CbGaD
Progesterone—ESR1—prostate cancer	0.0161	0.0617	CbGaD
Progesterone—Formestane—Estrone—prostate cancer	0.0159	0.0645	CrCrCtD
Progesterone—AR—Bicalutamide—prostate cancer	0.0145	0.0467	CbGbCtD
Progesterone—AR—Nilutamide—prostate cancer	0.0145	0.0467	CbGbCtD
Progesterone—Drostanolone—Estradiol—prostate cancer	0.0144	0.0584	CrCrCtD
Progesterone—NR3C1—prostate cancer	0.0142	0.0543	CbGaD
Progesterone—Formestane—Conjugated Estrogens—prostate cancer	0.014	0.0568	CrCrCtD
Progesterone—SLC10A1—Ethinyl Estradiol—prostate cancer	0.0139	0.0449	CbGbCtD
Progesterone—Testosterone Propionate—Estradiol valerate/Dienogest—prostate cancer	0.0131	0.0534	CrCrCtD
Progesterone—CYP2C19—prostate cancer	0.0129	0.0495	CbGaD
Progesterone—CYP1A1—prostate cancer	0.0129	0.0493	CbGaD
Progesterone—AR—Flutamide—prostate cancer	0.012	0.0387	CbGbCtD
Progesterone—ESR1—Estramustine—prostate cancer	0.0116	0.0376	CbGbCtD
Progesterone—SHBG—Estrone—prostate cancer	0.0104	0.0335	CbGbCtD
Progesterone—CYP1B1—Flutamide—prostate cancer	0.0104	0.0335	CbGbCtD
Progesterone—SLC10A1—Conjugated Estrogens—prostate cancer	0.0102	0.033	CbGbCtD
Progesterone—Testolactone—Estrone—prostate cancer	0.00992	0.0403	CrCrCtD
Progesterone—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.00972	0.0395	CrCrCtD
Progesterone—Testosterone—Estramustine—prostate cancer	0.0097	0.0394	CrCrCtD
Progesterone—SHBG—Ethinyl Estradiol—prostate cancer	0.00924	0.0298	CbGbCtD
Progesterone—Danazol—Ethinyl Estradiol—prostate cancer	0.00897	0.0364	CrCrCtD
Progesterone—CYP3A4—prostate cancer	0.00822	0.0315	CbGaD
Progesterone—Norethindrone—Ethinyl Estradiol—prostate cancer	0.0078	0.0317	CrCrCtD
Progesterone—Testosterone—Estrone—prostate cancer	0.00771	0.0313	CrCrCtD
Progesterone—CYP1B1—Estrone—prostate cancer	0.00749	0.0242	CbGbCtD
Progesterone—ESR1—Estrone—prostate cancer	0.00749	0.0242	CbGbCtD
Progesterone—ABCC1—Abiraterone—prostate cancer	0.00736	0.0238	CbGbCtD
Progesterone—ESR1—Ethinyl Estradiol—prostate cancer	0.00668	0.0216	CbGbCtD
Progesterone—ABCB11—Ethinyl Estradiol—prostate cancer	0.00668	0.0216	CbGbCtD
Progesterone—Methyltestosterone—Ethinyl Estradiol—prostate cancer	0.0064	0.026	CrCrCtD
Progesterone—SHBG—Estradiol—prostate cancer	0.00595	0.0192	CbGbCtD
Progesterone—Testosterone—Estradiol—prostate cancer	0.00584	0.0237	CrCrCtD
Progesterone—AR—Estradiol—prostate cancer	0.00498	0.0161	CbGbCtD
Progesterone—ESR1—Conjugated Estrogens—prostate cancer	0.0049	0.0158	CbGbCtD
Progesterone—SLC22A3—Estradiol—prostate cancer	0.00468	0.0151	CbGbCtD
Progesterone—CYP1A1—Flutamide—prostate cancer	0.00455	0.0147	CbGbCtD
Progesterone—CYP1B1—Mitoxantrone—prostate cancer	0.00446	0.0144	CbGbCtD
Progesterone—CYP1B1—Estradiol—prostate cancer	0.0043	0.0139	CbGbCtD
Progesterone—ESR1—Estradiol—prostate cancer	0.0043	0.0139	CbGbCtD
Progesterone—Potassium Canrenoate—Prednisone—prostate cancer	0.00373	0.0152	CrCrCtD
Progesterone—ABCC1—Conjugated Estrogens—prostate cancer	0.00348	0.0112	CbGbCtD
Progesterone—CYP1A1—Estrone—prostate cancer	0.00329	0.0106	CbGbCtD
Progesterone—CYP2C8—Nilutamide—prostate cancer	0.00317	0.0102	CbGbCtD
Progesterone—ABCC1—Mitoxantrone—prostate cancer	0.00317	0.0102	CbGbCtD
Progesterone—Danazol—Prednisone—prostate cancer	0.00315	0.0128	CrCrCtD
Progesterone—SLC22A2—Estradiol—prostate cancer	0.00277	0.00895	CbGbCtD
Progesterone—Hydrocortamate—Prednisone—prostate cancer	0.00274	0.0111	CrCrCtD
Progesterone—CYP3A5—Flutamide—prostate cancer	0.00273	0.00882	CbGbCtD
Progesterone—NR3C1—Prednisone—prostate cancer	0.00272	0.0088	CbGbCtD
Progesterone—CYP2C19—Nilutamide—prostate cancer	0.00266	0.00858	CbGbCtD
Progesterone—CYP2C19—Bicalutamide—prostate cancer	0.00266	0.00858	CbGbCtD
Progesterone—Cortisone acetate—Prednisone—prostate cancer	0.00266	0.0108	CrCrCtD
Progesterone—CYP2C8—Abiraterone—prostate cancer	0.00262	0.00848	CbGbCtD
Progesterone—Testolactone—Prednisone—prostate cancer	0.00258	0.0105	CrCrCtD
Progesterone—CYP1B1—Docetaxel—prostate cancer	0.00257	0.0083	CbGbCtD
Progesterone—ABCC1—Epirubicin—prostate cancer	0.00256	0.00828	CbGbCtD
Progesterone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00245	0.0079	CbGbCtD
Progesterone—SLC22A1—Estradiol—prostate cancer	0.00241	0.00778	CbGbCtD
Progesterone—Fludrocortisone—Prednisone—prostate cancer	0.00231	0.00937	CrCrCtD
Progesterone—Methyltestosterone—Prednisone—prostate cancer	0.00225	0.00914	CrCrCtD
Progesterone—CYP2C9—Bicalutamide—prostate cancer	0.00221	0.00714	CbGbCtD
Progesterone—CYP2C9—Nilutamide—prostate cancer	0.00221	0.00714	CbGbCtD
Progesterone—CYP2C19—Flutamide—prostate cancer	0.0022	0.00711	CbGbCtD
Progesterone—CYP1A2—Flutamide—prostate cancer	0.00203	0.00656	CbGbCtD
Progesterone—CYP2D6—Bicalutamide—prostate cancer	0.00202	0.00653	CbGbCtD
Progesterone—CYP3A5—Cabazitaxel—prostate cancer	0.00202	0.00652	CbGbCtD
Progesterone—ABCC1—Etoposide—prostate cancer	0.002	0.00645	CbGbCtD
Progesterone—ABCB1—Estramustine—prostate cancer	0.00199	0.00644	CbGbCtD
Progesterone—CYP3A5—Estrone—prostate cancer	0.00197	0.00637	CbGbCtD
Progesterone—Prednisolone—Prednisone—prostate cancer	0.00196	0.00797	CrCrCtD
Progesterone—CYP2C8—Cabazitaxel—prostate cancer	0.00194	0.00627	CbGbCtD
Progesterone—ABCB11—Doxorubicin—prostate cancer	0.00192	0.00619	CbGbCtD
Progesterone—CYP1B1—Doxorubicin—prostate cancer	0.00192	0.00619	CbGbCtD
Progesterone—CYP1A1—Estradiol—prostate cancer	0.00189	0.0061	CbGbCtD
Progesterone—Hydrocortisone—Prednisone—prostate cancer	0.00188	0.00764	CrCrCtD
Progesterone—ABCC1—Docetaxel—prostate cancer	0.00183	0.0059	CbGbCtD
Progesterone—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00169	0.00546	CbGbCtD
Progesterone—CYP2D6—Abiraterone—prostate cancer	0.00167	0.00541	CbGbCtD
Progesterone—CYP3A7—Estradiol—prostate cancer	0.00151	0.00488	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.00151	0.00488	CbGbCtD
Progesterone—CYP1A2—Estrone—prostate cancer	0.00147	0.00474	CbGbCtD
Progesterone—SHBG—semen—prostate cancer	0.00147	0.0641	CbGeAlD
Progesterone—ABCC1—Doxorubicin—prostate cancer	0.00136	0.0044	CbGbCtD
Progesterone—CYP2C9—Estrone—prostate cancer	0.00132	0.00427	CbGbCtD
Progesterone—ABCB1—Cabazitaxel—prostate cancer	0.00131	0.00424	CbGbCtD
Progesterone—CYP3A4—Bicalutamide—prostate cancer	0.00128	0.00415	CbGbCtD
Progesterone—ABCB1—Estrone—prostate cancer	0.00128	0.00415	CbGbCtD
Progesterone—CYP3A4—Estramustine—prostate cancer	0.00119	0.00386	CbGbCtD
Progesterone—ABCB1—Ethinyl Estradiol—prostate cancer	0.00114	0.0037	CbGbCtD
Progesterone—CYP3A5—Estradiol—prostate cancer	0.00113	0.00366	CbGbCtD
Progesterone—AR—penis—prostate cancer	0.00111	0.0483	CbGeAlD
Progesterone—CYP2C8—Estradiol—prostate cancer	0.00109	0.00352	CbGbCtD
Progesterone—CYP3A4—Flutamide—prostate cancer	0.00106	0.00344	CbGbCtD
Progesterone—CYP3A4—Abiraterone—prostate cancer	0.00106	0.00344	CbGbCtD
Progesterone—AR—semen—prostate cancer	0.00105	0.046	CbGeAlD
Progesterone—CYP2C9—Capecitabine—prostate cancer	0.001	0.00324	CbGbCtD
Progesterone—CYP1A2—Conjugated Estrogens—prostate cancer	0.000961	0.0031	CbGbCtD
Progesterone—CYP2C19—Estradiol—prostate cancer	0.000914	0.00295	CbGbCtD
Progesterone—CYP3A7—Docetaxel—prostate cancer	0.000903	0.00292	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.000903	0.00292	CbGbCtD
Progesterone—CYP1A2—Estradiol—prostate cancer	0.000844	0.00272	CbGbCtD
Progesterone—ABCB1—Conjugated Estrogens—prostate cancer	0.00084	0.00271	CbGbCtD
Progesterone—CYP3A4—Cabazitaxel—prostate cancer	0.000787	0.00254	CbGbCtD
Progesterone—CYP2C19—Prednisone—prostate cancer	0.000786	0.00254	CbGbCtD
Progesterone—CYP3A4—Estrone—prostate cancer	0.00077	0.00249	CbGbCtD
Progesterone—ABCB1—Mitoxantrone—prostate cancer	0.000764	0.00247	CbGbCtD
Progesterone—CYP2C9—Estradiol—prostate cancer	0.00076	0.00246	CbGbCtD
Progesterone—CYP3A5—Etoposide—prostate cancer	0.00074	0.00239	CbGbCtD
Progesterone—ABCB1—Estradiol—prostate cancer	0.000738	0.00238	CbGbCtD
Progesterone—CYP2C8—Etoposide—prostate cancer	0.000712	0.0023	CbGbCtD
Progesterone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.000686	0.00222	CbGbCtD
Progesterone—CYP2C19—urine—prostate cancer	0.000682	0.0298	CbGeAlD
Progesterone—CYP3A5—Docetaxel—prostate cancer	0.000677	0.00219	CbGbCtD
Progesterone—ABCB1—Prednisone—prostate cancer	0.000634	0.00205	CbGbCtD
Progesterone—SLC10A1—prostate gland—prostate cancer	0.000566	0.0248	CbGeAlD
Progesterone—CYP1A2—urine—prostate cancer	0.000557	0.0243	CbGeAlD
Progesterone—CYP1A2—Etoposide—prostate cancer	0.000551	0.00178	CbGbCtD
Progesterone—NR3C1—urine—prostate cancer	0.000533	0.0233	CbGeAlD
Progesterone—CYP2C9—urine—prostate cancer	0.000528	0.0231	CbGeAlD
Progesterone—CYP3A4—Conjugated Estrogens—prostate cancer	0.000503	0.00163	CbGbCtD
Progesterone—OPRK1—prostate gland—prostate cancer	0.000499	0.0218	CbGeAlD
Progesterone—ABCB1—Etoposide—prostate cancer	0.000482	0.00156	CbGbCtD
Progesterone—SLC10A1—seminal vesicle—prostate cancer	0.000479	0.0209	CbGeAlD
Progesterone—CYP3A4—Mitoxantrone—prostate cancer	0.000458	0.00148	CbGbCtD
Progesterone—CYP3A4—Estradiol—prostate cancer	0.000442	0.00143	CbGbCtD
Progesterone—ABCB1—Docetaxel—prostate cancer	0.000441	0.00142	CbGbCtD
Progesterone—CYP3A4—urine—prostate cancer	0.000403	0.0176	CbGeAlD
Progesterone—CYP2D6—urine—prostate cancer	0.000396	0.0173	CbGeAlD
Progesterone—SLC10A1—renal system—prostate cancer	0.000386	0.0169	CbGeAlD
Progesterone—CYP2A6—prostate gland—prostate cancer	0.00038	0.0166	CbGeAlD
Progesterone—CYP3A4—Prednisone—prostate cancer	0.00038	0.00123	CbGbCtD
Progesterone—SHBG—prostate gland—prostate cancer	0.000368	0.0161	CbGeAlD
Progesterone—NR3C2—prostate gland—prostate cancer	0.000357	0.0156	CbGeAlD
Progesterone—SIGMAR1—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.000352	1	CbGdCrCtD
Progesterone—CYP17A1—renal system—prostate cancer	0.000336	0.0147	CbGeAlD
Progesterone—PGR—prostate gland—prostate cancer	0.000331	0.0145	CbGeAlD
Progesterone—ABCB1—Doxorubicin—prostate cancer	0.000329	0.00106	CbGbCtD
Progesterone—CYP2A6—seminal vesicle—prostate cancer	0.000322	0.0141	CbGeAlD
Progesterone—CYP2D6—Doxorubicin—prostate cancer	0.00031	0.001	CbGbCtD
Progesterone—SLC22A2—renal system—prostate cancer	0.000306	0.0134	CbGeAlD
Progesterone—SLC22A3—prostate gland—prostate cancer	0.000303	0.0133	CbGeAlD
Progesterone—NR3C2—seminal vesicle—prostate cancer	0.000302	0.0132	CbGeAlD
Progesterone—SIGMAR1—prostate gland—prostate cancer	0.000293	0.0128	CbGeAlD
Progesterone—CYP3A4—Etoposide—prostate cancer	0.000289	0.000932	CbGbCtD
Progesterone—CYP1B1—prostate gland—prostate cancer	0.000279	0.0122	CbGeAlD
Progesterone—CYP3A4—Docetaxel—prostate cancer	0.000264	0.000853	CbGbCtD
Progesterone—AR—prostate gland—prostate cancer	0.000264	0.0115	CbGeAlD
Progesterone—ESR1—prostate gland—prostate cancer	0.000259	0.0113	CbGeAlD
Progesterone—SLC22A3—seminal vesicle—prostate cancer	0.000257	0.0112	CbGeAlD
Progesterone—ABCC1—prostate gland—prostate cancer	0.000251	0.011	CbGeAlD
Progesterone—SLC10A1—testis—prostate cancer	0.00025	0.0109	CbGeAlD
Progesterone—SIGMAR1—seminal vesicle—prostate cancer	0.000248	0.0108	CbGeAlD
Progesterone—ABCB11—testis—prostate cancer	0.000247	0.0108	CbGeAlD
Progesterone—PGR—epithelium—prostate cancer	0.000244	0.0106	CbGeAlD
Progesterone—NR3C2—renal system—prostate cancer	0.000243	0.0106	CbGeAlD
Progesterone—Trilostane—HSD3B1—prostate cancer	0.000241	0.093	CrCbGaD
Progesterone—NR3C2—urethra—prostate cancer	0.000239	0.0104	CbGeAlD
Progesterone—AR—seminal vesicle—prostate cancer	0.000223	0.00976	CbGeAlD
Progesterone—CYP17A1—testis—prostate cancer	0.000217	0.0095	CbGeAlD
Progesterone—SLC22A1—renal system—prostate cancer	0.000216	0.00945	CbGeAlD
Progesterone—ABCC1—seminal vesicle—prostate cancer	0.000212	0.00927	CbGeAlD
Progesterone—SLC22A3—renal system—prostate cancer	0.000207	0.00903	CbGeAlD
Progesterone—SLC22A3—urethra—prostate cancer	0.000203	0.00888	CbGeAlD
Progesterone—CYP3A4—Doxorubicin—prostate cancer	0.000197	0.000636	CbGbCtD
Progesterone—SIGMAR1—urethra—prostate cancer	0.000196	0.00858	CbGeAlD
Progesterone—AR—epithelium—prostate cancer	0.000194	0.00848	CbGeAlD
Progesterone—CYP3A5—prostate gland—prostate cancer	0.000193	0.00842	CbGeAlD
Progesterone—NR3C1—prostate gland—prostate cancer	0.000191	0.00836	CbGeAlD
Progesterone—ESR1—epithelium—prostate cancer	0.00019	0.00832	CbGeAlD
Progesterone—CYP1B1—renal system—prostate cancer	0.00019	0.0083	CbGeAlD
Progesterone—SHBG—bone marrow—prostate cancer	0.00019	0.00829	CbGeAlD
Progesterone—AR—renal system—prostate cancer	0.00018	0.00786	CbGeAlD
Progesterone—AR—urethra—prostate cancer	0.000177	0.00773	CbGeAlD
Progesterone—ESR1—renal system—prostate cancer	0.000177	0.00772	CbGeAlD
Progesterone—ABCC1—urethra—prostate cancer	0.000168	0.00734	CbGeAlD
Progesterone—Trilostane—HSD3B2—prostate cancer	0.000163	0.0628	CrCbGaD
Progesterone—SHBG—testis—prostate cancer	0.000162	0.00708	CbGeAlD
Progesterone—NR3C1—seminal vesicle—prostate cancer	0.000162	0.00707	CbGeAlD
Progesterone—CYP17A1—lymph node—prostate cancer	0.000158	0.00689	CbGeAlD
Progesterone—NR3C2—testis—prostate cancer	0.000157	0.00686	CbGeAlD
Progesterone—Finasteride—SRD5A2—prostate cancer	0.000154	0.0595	CrCbGaD
Progesterone—SIGMAR1—bone marrow—prostate cancer	0.000151	0.0066	CbGeAlD
Progesterone—PGR—testis—prostate cancer	0.000146	0.00638	CbGeAlD
Progesterone—CYP2C8—renal system—prostate cancer	0.000146	0.00636	CbGeAlD
Progesterone—CYP1A1—epithelium—prostate cancer	0.000145	0.00633	CbGeAlD
Progesterone—NR3C1—epithelium—prostate cancer	0.000141	0.00614	CbGeAlD
Progesterone—CYP1A2—renal system—prostate cancer	0.000136	0.00595	CbGeAlD
Progesterone—CYP1A1—renal system—prostate cancer	0.000134	0.00587	CbGeAlD
Progesterone—SLC22A3—testis—prostate cancer	0.000134	0.00584	CbGeAlD
Progesterone—CYP1A1—urethra—prostate cancer	0.000132	0.00577	CbGeAlD
Progesterone—CYP3A5—renal system—prostate cancer	0.000131	0.00574	CbGeAlD
Progesterone—NR3C1—renal system—prostate cancer	0.00013	0.0057	CbGeAlD
Progesterone—SIGMAR1—testis—prostate cancer	0.000129	0.00564	CbGeAlD
Progesterone—NR3C1—urethra—prostate cancer	0.000128	0.0056	CbGeAlD
Progesterone—CYP1B1—testis—prostate cancer	0.000123	0.00537	CbGeAlD
Progesterone—Finasteride—SRD5A1—prostate cancer	0.000117	0.0451	CrCbGaD
Progesterone—AR—testis—prostate cancer	0.000116	0.00508	CbGeAlD
Progesterone—ESR1—testis—prostate cancer	0.000114	0.00499	CbGeAlD
Progesterone—NR3C2—lymph node—prostate cancer	0.000114	0.00498	CbGeAlD
Progesterone—ABCC1—testis—prostate cancer	0.00011	0.00483	CbGeAlD
Progesterone—PGR—lymph node—prostate cancer	0.000106	0.00462	CbGeAlD
Progesterone—ABCB1—prostate gland—prostate cancer	0.000102	0.00447	CbGeAlD
Progesterone—CYP3A4—renal system—prostate cancer	9.86e-05	0.00431	CbGeAlD
Progesterone—NR3C1—bone marrow—prostate cancer	9.86e-05	0.00431	CbGeAlD
Progesterone—CYP2D6—renal system—prostate cancer	9.7e-05	0.00424	CbGeAlD
Progesterone—SLC22A3—lymph node—prostate cancer	9.69e-05	0.00423	CbGeAlD
Progesterone—CYP2C8—testis—prostate cancer	9.41e-05	0.00411	CbGeAlD
Progesterone—SIGMAR1—lymph node—prostate cancer	9.36e-05	0.00409	CbGeAlD
Progesterone—CYP1B1—lymph node—prostate cancer	8.9e-05	0.00389	CbGeAlD
Progesterone—ABCB1—seminal vesicle—prostate cancer	8.66e-05	0.00378	CbGeAlD
Progesterone—AR—lymph node—prostate cancer	8.43e-05	0.00368	CbGeAlD
Progesterone—NR3C1—testis—prostate cancer	8.42e-05	0.00368	CbGeAlD
Progesterone—ESR1—lymph node—prostate cancer	8.28e-05	0.00362	CbGeAlD
Progesterone—ABCC1—lymph node—prostate cancer	8.01e-05	0.0035	CbGeAlD
Progesterone—Levonorgestrel—SRD5A1—prostate cancer	7.82e-05	0.0302	CrCbGaD
Progesterone—Medroxyprogesterone Acetate—HSD3B2—prostate cancer	7.52e-05	0.0291	CrCbGaD
Progesterone—ABCB1—epithelium—prostate cancer	7.52e-05	0.00329	CbGeAlD
Progesterone—ABCB1—renal system—prostate cancer	6.98e-05	0.00305	CbGeAlD
Progesterone—ABCB1—urethra—prostate cancer	6.85e-05	0.003	CbGeAlD
Progesterone—Stanozolol—AR—prostate cancer	6.54e-05	0.0253	CrCbGaD
Progesterone—CYP1A1—lymph node—prostate cancer	6.29e-05	0.00275	CbGeAlD
Progesterone—CYP2D6—testis—prostate cancer	6.27e-05	0.00274	CbGeAlD
Progesterone—NR3C1—lymph node—prostate cancer	6.11e-05	0.00267	CbGeAlD
Progesterone—Oxandrolone—AR—prostate cancer	5.89e-05	0.0227	CrCbGaD
Progesterone—ABCB1—bone marrow—prostate cancer	5.28e-05	0.00231	CbGeAlD
Progesterone—Trilostane—ESR2—prostate cancer	5.13e-05	0.0198	CrCbGaD
Progesterone—Nandrolone phenpropionate—AR—prostate cancer	4.61e-05	0.0178	CrCbGaD
Progesterone—ABCB1—testis—prostate cancer	4.51e-05	0.00197	CbGeAlD
Progesterone—Drostanolone—SHBG—prostate cancer	4.47e-05	0.0173	CrCbGaD
Progesterone—Medroxyprogesterone Acetate—AKR1C3—prostate cancer	4.17e-05	0.0161	CrCbGaD
Progesterone—Testosterone Propionate—CYP17A1—prostate cancer	3.93e-05	0.0152	CrCbGaD
Progesterone—Drostanolone—AR—prostate cancer	3.92e-05	0.0151	CrCbGaD
Progesterone—Hydrocortisone—ANXA1—prostate cancer	3.86e-05	0.0149	CrCbGaD
Progesterone—Nandrolone phenpropionate—CYP19A1—prostate cancer	3.86e-05	0.0149	CrCbGaD
Progesterone—Testosterone—CYP3A43—prostate cancer	3.76e-05	0.0145	CrCbGaD
Progesterone—Testolactone—CYP19A1—prostate cancer	3.68e-05	0.0142	CrCbGaD
Progesterone—Nandrolone decanoate—AR—prostate cancer	3.49e-05	0.0135	CrCbGaD
Progesterone—Ethynodiol—ESR1—prostate cancer	3.44e-05	0.0133	CrCbGaD
Progesterone—Drostanolone—CYP19A1—prostate cancer	3.28e-05	0.0127	CrCbGaD
Progesterone—ABCB1—lymph node—prostate cancer	3.27e-05	0.00143	CbGeAlD
Progesterone—Testosterone Propionate—COMT—prostate cancer	3.2e-05	0.0124	CrCbGaD
Progesterone—Trilostane—ESR1—prostate cancer	3.16e-05	0.0122	CrCbGaD
Progesterone—Finasteride—CYP3A5—prostate cancer	3.14e-05	0.0121	CrCbGaD
Progesterone—Nandrolone decanoate—CYP19A1—prostate cancer	2.92e-05	0.0113	CrCbGaD
Progesterone—Norgestimate—ESR1—prostate cancer	2.92e-05	0.0113	CrCbGaD
Progesterone—Drospirenone—AR—prostate cancer	2.85e-05	0.011	CrCbGaD
Progesterone—Eplerenone—CYP3A5—prostate cancer	2.7e-05	0.0104	CrCbGaD
Progesterone—Fludrocortisone—AR—prostate cancer	2.68e-05	0.0104	CrCbGaD
Progesterone—Levonorgestrel—SHBG—prostate cancer	2.65e-05	0.0102	CrCbGaD
Progesterone—Fluoxymesterone—SHBG—prostate cancer	2.52e-05	0.00975	CrCbGaD
Progesterone—Medrysone—NR3C1—prostate cancer	2.5e-05	0.00965	CrCbGaD
Progesterone—Danazol—SHBG—prostate cancer	2.41e-05	0.00932	CrCbGaD
Progesterone—Testosterone Propionate—AR—prostate cancer	2.39e-05	0.00923	CrCbGaD
Progesterone—Hydrocortamate—NR3C1—prostate cancer	2.33e-05	0.009	CrCbGaD
Progesterone—Levonorgestrel—AR—prostate cancer	2.32e-05	0.00897	CrCbGaD
Progesterone—Spironolactone—SHBG—prostate cancer	2.31e-05	0.00893	CrCbGaD
Progesterone—Cortisone acetate—NR3C1—prostate cancer	2.29e-05	0.00886	CrCbGaD
Progesterone—Fluoxymesterone—AR—prostate cancer	2.21e-05	0.00855	CrCbGaD
Progesterone—Megestrol acetate—NR3C1—prostate cancer	2.21e-05	0.00854	CrCbGaD
Progesterone—Medroxyprogesterone Acetate—SHBG—prostate cancer	2.17e-05	0.00836	CrCbGaD
Progesterone—Norethindrone—SHBG—prostate cancer	2.15e-05	0.00829	CrCbGaD
Progesterone—Danazol—AR—prostate cancer	2.12e-05	0.00817	CrCbGaD
Progesterone—Methyltestosterone—SHBG—prostate cancer	2.04e-05	0.00787	CrCbGaD
Progesterone—Spironolactone—AR—prostate cancer	2.03e-05	0.00783	CrCbGaD
Progesterone—Levonorgestrel—CYP19A1—prostate cancer	1.94e-05	0.00751	CrCbGaD
Progesterone—Medroxyprogesterone Acetate—AR—prostate cancer	1.9e-05	0.00733	CrCbGaD
Progesterone—Fludrocortisone—NR3C1—prostate cancer	1.82e-05	0.00702	CrCbGaD
Progesterone—Levonorgestrel—ESR1—prostate cancer	1.79e-05	0.00691	CrCbGaD
Progesterone—Methyltestosterone—AR—prostate cancer	1.79e-05	0.0069	CrCbGaD
Progesterone—Danazol—CYP19A1—prostate cancer	1.77e-05	0.00684	CrCbGaD
Progesterone—Norethindrone—CYP3A5—prostate cancer	1.71e-05	0.0066	CrCbGaD
Progesterone—Fluoxymesterone—ESR1—prostate cancer	1.7e-05	0.00659	CrCbGaD
Progesterone—Danazol—ESR1—prostate cancer	1.63e-05	0.00629	CrCbGaD
Progesterone—Testosterone—SLC22A3—prostate cancer	1.63e-05	0.00628	CrCbGaD
Progesterone—Prednisolone—CYP2A6—prostate cancer	1.55e-05	0.00598	CrCbGaD
Progesterone—Hydrocortisone—SHBG—prostate cancer	1.54e-05	0.00593	CrCbGaD
Progesterone—Fluoxymesterone—NR3C1—prostate cancer	1.5e-05	0.0058	CrCbGaD
Progesterone—Methyltestosterone—CYP19A1—prostate cancer	1.5e-05	0.00578	CrCbGaD
Progesterone—Medroxyprogesterone Acetate—ESR1—prostate cancer	1.46e-05	0.00565	CrCbGaD
Progesterone—Spironolactone—NR3C1—prostate cancer	1.37e-05	0.00531	CrCbGaD
Progesterone—Finasteride—CYP3A4—prostate cancer	1.36e-05	0.00526	CrCbGaD
Progesterone—Hydrocortamate—CYP3A4—prostate cancer	1.35e-05	0.00522	CrCbGaD
Progesterone—Cortisone acetate—CYP3A4—prostate cancer	1.33e-05	0.00513	CrCbGaD
Progesterone—Medroxyprogesterone Acetate—NR3C1—prostate cancer	1.29e-05	0.00497	CrCbGaD
Progesterone—Hydrocortisone—CYP3A5—prostate cancer	1.22e-05	0.00472	CrCbGaD
Progesterone—Prednisolone—NR3C1—prostate cancer	1.19e-05	0.00461	CrCbGaD
Progesterone—Testosterone—SHBG—prostate cancer	1.18e-05	0.00457	CrCbGaD
Progesterone—Testosterone—CYP1B1—prostate cancer	1.18e-05	0.00457	CrCbGaD
Progesterone—Eplerenone—CYP3A4—prostate cancer	1.17e-05	0.00451	CrCbGaD
Progesterone—Testosterone—SLC22A1—prostate cancer	1.17e-05	0.00451	CrCbGaD
Progesterone—Norethindrone—CYP2C19—prostate cancer	1.16e-05	0.00449	CrCbGaD
Progesterone—Drospirenone—PTGS2—prostate cancer	1.1e-05	0.00423	CrCbGaD
Progesterone—Testosterone—AR—prostate cancer	1.04e-05	0.004	CrCbGaD
Progesterone—Testosterone—CYP3A5—prostate cancer	9.42e-06	0.00364	CrCbGaD
Progesterone—Levonorgestrel—CYP3A4—prostate cancer	9.13e-06	0.00353	CrCbGaD
Progesterone—Hydrocortisone—NR3C1—prostate cancer	9.13e-06	0.00353	CrCbGaD
Progesterone—Testosterone—CYP19A1—prostate cancer	8.68e-06	0.00335	CrCbGaD
Progesterone—Danazol—CYP3A4—prostate cancer	8.32e-06	0.00321	CrCbGaD
Progesterone—Headache—Mitoxantrone—prostate cancer	7.61e-06	7.9e-05	CcSEcCtD
Progesterone—Hypotension—Capecitabine—prostate cancer	7.6e-06	7.89e-05	CcSEcCtD
Progesterone—Insomnia—Docetaxel—prostate cancer	7.6e-06	7.89e-05	CcSEcCtD
Progesterone—Myalgia—Prednisone—prostate cancer	7.56e-06	7.85e-05	CcSEcCtD
Progesterone—Arthralgia—Prednisone—prostate cancer	7.56e-06	7.85e-05	CcSEcCtD
Progesterone—Paraesthesia—Docetaxel—prostate cancer	7.54e-06	7.83e-05	CcSEcCtD
Progesterone—Erythema multiforme—Epirubicin—prostate cancer	7.54e-06	7.83e-05	CcSEcCtD
Progesterone—Anxiety—Prednisone—prostate cancer	7.53e-06	7.82e-05	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	7.5e-06	7.79e-05	CcSEcCtD
Progesterone—Dyspnoea—Docetaxel—prostate cancer	7.49e-06	7.77e-05	CcSEcCtD
Progesterone—Somnolence—Docetaxel—prostate cancer	7.47e-06	7.75e-05	CcSEcCtD
Progesterone—Discomfort—Prednisone—prostate cancer	7.47e-06	7.75e-05	CcSEcCtD
Progesterone—Medroxyprogesterone Acetate—CYP3A4—prostate cancer	7.46e-06	0.00288	CrCbGaD
Progesterone—Eye disorder—Epirubicin—prostate cancer	7.45e-06	7.74e-05	CcSEcCtD
Progesterone—Hypersensitivity—Etoposide—prostate cancer	7.45e-06	7.73e-05	CcSEcCtD
Progesterone—Tinnitus—Epirubicin—prostate cancer	7.44e-06	7.72e-05	CcSEcCtD
Progesterone—Haemoglobin—Doxorubicin—prostate cancer	7.42e-06	7.7e-05	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Capecitabine—prostate cancer	7.41e-06	7.69e-05	CcSEcCtD
Progesterone—Cardiac disorder—Epirubicin—prostate cancer	7.4e-06	7.68e-05	CcSEcCtD
Progesterone—Norethindrone—CYP3A4—prostate cancer	7.4e-06	0.00286	CrCbGaD
Progesterone—Rhinitis—Doxorubicin—prostate cancer	7.4e-06	7.68e-05	CcSEcCtD
Progesterone—Dyspepsia—Docetaxel—prostate cancer	7.39e-06	7.68e-05	CcSEcCtD
Progesterone—Haemorrhage—Doxorubicin—prostate cancer	7.38e-06	7.66e-05	CcSEcCtD
Progesterone—Hepatitis—Doxorubicin—prostate cancer	7.38e-06	7.66e-05	CcSEcCtD
Progesterone—Insomnia—Capecitabine—prostate cancer	7.36e-06	7.64e-05	CcSEcCtD
Progesterone—Pharyngitis—Doxorubicin—prostate cancer	7.32e-06	7.6e-05	CcSEcCtD
Progesterone—Paraesthesia—Capecitabine—prostate cancer	7.3e-06	7.58e-05	CcSEcCtD
Progesterone—Decreased appetite—Docetaxel—prostate cancer	7.3e-06	7.58e-05	CcSEcCtD
Progesterone—Urinary tract disorder—Doxorubicin—prostate cancer	7.29e-06	7.56e-05	CcSEcCtD
Progesterone—Oedema peripheral—Doxorubicin—prostate cancer	7.27e-06	7.55e-05	CcSEcCtD
Progesterone—Gastrointestinal disorder—Docetaxel—prostate cancer	7.25e-06	7.53e-05	CcSEcCtD
Progesterone—Asthenia—Etoposide—prostate cancer	7.25e-06	7.53e-05	CcSEcCtD
Progesterone—Connective tissue disorder—Doxorubicin—prostate cancer	7.25e-06	7.53e-05	CcSEcCtD
Progesterone—Dyspnoea—Capecitabine—prostate cancer	7.25e-06	7.53e-05	CcSEcCtD
Progesterone—Oedema—Prednisone—prostate cancer	7.24e-06	7.52e-05	CcSEcCtD
Progesterone—Anaphylactic shock—Prednisone—prostate cancer	7.24e-06	7.52e-05	CcSEcCtD
Progesterone—Fatigue—Docetaxel—prostate cancer	7.24e-06	7.52e-05	CcSEcCtD
Progesterone—Angiopathy—Epirubicin—prostate cancer	7.24e-06	7.51e-05	CcSEcCtD
Progesterone—Urethral disorder—Doxorubicin—prostate cancer	7.23e-06	7.51e-05	CcSEcCtD
Progesterone—Nausea—Mitoxantrone—prostate cancer	7.22e-06	7.49e-05	CcSEcCtD
Progesterone—Immune system disorder—Epirubicin—prostate cancer	7.2e-06	7.48e-05	CcSEcCtD
Progesterone—Infection—Prednisone—prostate cancer	7.2e-06	7.47e-05	CcSEcCtD
Progesterone—Mediastinal disorder—Epirubicin—prostate cancer	7.19e-06	7.46e-05	CcSEcCtD
Progesterone—Pain—Docetaxel—prostate cancer	7.18e-06	7.46e-05	CcSEcCtD
Progesterone—Constipation—Docetaxel—prostate cancer	7.18e-06	7.46e-05	CcSEcCtD
Progesterone—Dyspepsia—Capecitabine—prostate cancer	7.16e-06	7.43e-05	CcSEcCtD
Progesterone—Pruritus—Etoposide—prostate cancer	7.15e-06	7.42e-05	CcSEcCtD
Progesterone—Shock—Prednisone—prostate cancer	7.13e-06	7.4e-05	CcSEcCtD
Progesterone—Visual impairment—Doxorubicin—prostate cancer	7.11e-06	7.38e-05	CcSEcCtD
Progesterone—Nervous system disorder—Prednisone—prostate cancer	7.1e-06	7.38e-05	CcSEcCtD
Progesterone—Tachycardia—Prednisone—prostate cancer	7.07e-06	7.34e-05	CcSEcCtD
Progesterone—Decreased appetite—Capecitabine—prostate cancer	7.07e-06	7.34e-05	CcSEcCtD
Progesterone—Alopecia—Epirubicin—prostate cancer	7.05e-06	7.32e-05	CcSEcCtD
Progesterone—Skin disorder—Prednisone—prostate cancer	7.04e-06	7.3e-05	CcSEcCtD
Progesterone—Methyltestosterone—CYP3A4—prostate cancer	7.03e-06	0.00271	CrCbGaD
Progesterone—Gastrointestinal disorder—Capecitabine—prostate cancer	7.02e-06	7.29e-05	CcSEcCtD
Progesterone—Fatigue—Capecitabine—prostate cancer	7.01e-06	7.28e-05	CcSEcCtD
Progesterone—Hyperhidrosis—Prednisone—prostate cancer	7e-06	7.27e-05	CcSEcCtD
Progesterone—Mental disorder—Epirubicin—prostate cancer	6.99e-06	7.25e-05	CcSEcCtD
Progesterone—Erythema multiforme—Doxorubicin—prostate cancer	6.98e-06	7.24e-05	CcSEcCtD
Progesterone—Pain—Capecitabine—prostate cancer	6.95e-06	7.22e-05	CcSEcCtD
Progesterone—Constipation—Capecitabine—prostate cancer	6.95e-06	7.22e-05	CcSEcCtD
Progesterone—Malnutrition—Epirubicin—prostate cancer	6.94e-06	7.21e-05	CcSEcCtD
Progesterone—Erythema—Epirubicin—prostate cancer	6.94e-06	7.21e-05	CcSEcCtD
Progesterone—Feeling abnormal—Docetaxel—prostate cancer	6.92e-06	7.19e-05	CcSEcCtD
Progesterone—Prednisolone—CYP3A4—prostate cancer	6.92e-06	0.00267	CrCbGaD
Progesterone—Diarrhoea—Etoposide—prostate cancer	6.92e-06	7.18e-05	CcSEcCtD
Progesterone—Anorexia—Prednisone—prostate cancer	6.91e-06	7.17e-05	CcSEcCtD
Progesterone—Eye disorder—Doxorubicin—prostate cancer	6.9e-06	7.16e-05	CcSEcCtD
Progesterone—Tinnitus—Doxorubicin—prostate cancer	6.88e-06	7.14e-05	CcSEcCtD
Progesterone—Gastrointestinal pain—Docetaxel—prostate cancer	6.87e-06	7.13e-05	CcSEcCtD
Progesterone—Cardiac disorder—Doxorubicin—prostate cancer	6.85e-06	7.11e-05	CcSEcCtD
Progesterone—Flatulence—Epirubicin—prostate cancer	6.84e-06	7.1e-05	CcSEcCtD
Progesterone—Tension—Epirubicin—prostate cancer	6.81e-06	7.07e-05	CcSEcCtD
Progesterone—Nervousness—Epirubicin—prostate cancer	6.74e-06	7e-05	CcSEcCtD
Progesterone—Back pain—Epirubicin—prostate cancer	6.72e-06	6.97e-05	CcSEcCtD
Progesterone—Feeling abnormal—Capecitabine—prostate cancer	6.7e-06	6.96e-05	CcSEcCtD
Progesterone—Angiopathy—Doxorubicin—prostate cancer	6.69e-06	6.95e-05	CcSEcCtD
Progesterone—Dizziness—Etoposide—prostate cancer	6.68e-06	6.94e-05	CcSEcCtD
Progesterone—Muscle spasms—Epirubicin—prostate cancer	6.67e-06	6.93e-05	CcSEcCtD
Progesterone—Immune system disorder—Doxorubicin—prostate cancer	6.66e-06	6.92e-05	CcSEcCtD
Progesterone—Gastrointestinal pain—Capecitabine—prostate cancer	6.65e-06	6.9e-05	CcSEcCtD
Progesterone—Mediastinal disorder—Doxorubicin—prostate cancer	6.65e-06	6.9e-05	CcSEcCtD
Progesterone—Abdominal pain—Docetaxel—prostate cancer	6.64e-06	6.89e-05	CcSEcCtD
Progesterone—Body temperature increased—Docetaxel—prostate cancer	6.64e-06	6.89e-05	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Prednisone—prostate cancer	6.6e-06	6.85e-05	CcSEcCtD
Progesterone—Insomnia—Prednisone—prostate cancer	6.55e-06	6.8e-05	CcSEcCtD
Progesterone—Vision blurred—Epirubicin—prostate cancer	6.54e-06	6.79e-05	CcSEcCtD
Progesterone—Alopecia—Doxorubicin—prostate cancer	6.52e-06	6.77e-05	CcSEcCtD
Progesterone—Paraesthesia—Prednisone—prostate cancer	6.5e-06	6.75e-05	CcSEcCtD
Progesterone—Mental disorder—Doxorubicin—prostate cancer	6.46e-06	6.71e-05	CcSEcCtD
Progesterone—Urticaria—Capecitabine—prostate cancer	6.46e-06	6.71e-05	CcSEcCtD
Progesterone—Ill-defined disorder—Epirubicin—prostate cancer	6.44e-06	6.69e-05	CcSEcCtD
Progesterone—Abdominal pain—Capecitabine—prostate cancer	6.43e-06	6.67e-05	CcSEcCtD
Progesterone—Body temperature increased—Capecitabine—prostate cancer	6.43e-06	6.67e-05	CcSEcCtD
Progesterone—Vomiting—Etoposide—prostate cancer	6.43e-06	6.67e-05	CcSEcCtD
Progesterone—Erythema—Doxorubicin—prostate cancer	6.42e-06	6.67e-05	CcSEcCtD
Progesterone—Malnutrition—Doxorubicin—prostate cancer	6.42e-06	6.67e-05	CcSEcCtD
Progesterone—Anaemia—Epirubicin—prostate cancer	6.42e-06	6.66e-05	CcSEcCtD
Progesterone—Testosterone—CYP2C19—prostate cancer	6.41e-06	0.00248	CrCbGaD
Progesterone—Testosterone—CYP1A1—prostate cancer	6.38e-06	0.00247	CrCbGaD
Progesterone—Dyspepsia—Prednisone—prostate cancer	6.38e-06	6.62e-05	CcSEcCtD
Progesterone—Rash—Etoposide—prostate cancer	6.37e-06	6.62e-05	CcSEcCtD
Progesterone—Dermatitis—Etoposide—prostate cancer	6.37e-06	6.61e-05	CcSEcCtD
Progesterone—Headache—Etoposide—prostate cancer	6.33e-06	6.57e-05	CcSEcCtD
Progesterone—Flatulence—Doxorubicin—prostate cancer	6.33e-06	6.57e-05	CcSEcCtD
Progesterone—Tension—Doxorubicin—prostate cancer	6.3e-06	6.54e-05	CcSEcCtD
Progesterone—Decreased appetite—Prednisone—prostate cancer	6.3e-06	6.54e-05	CcSEcCtD
Progesterone—Malaise—Epirubicin—prostate cancer	6.26e-06	6.5e-05	CcSEcCtD
Progesterone—Fatigue—Prednisone—prostate cancer	6.25e-06	6.48e-05	CcSEcCtD
Progesterone—Nervousness—Doxorubicin—prostate cancer	6.24e-06	6.48e-05	CcSEcCtD
Progesterone—Vertigo—Epirubicin—prostate cancer	6.24e-06	6.47e-05	CcSEcCtD
Progesterone—Syncope—Epirubicin—prostate cancer	6.23e-06	6.46e-05	CcSEcCtD
Progesterone—Back pain—Doxorubicin—prostate cancer	6.21e-06	6.45e-05	CcSEcCtD
Progesterone—Constipation—Prednisone—prostate cancer	6.19e-06	6.43e-05	CcSEcCtD
Progesterone—Hypersensitivity—Docetaxel—prostate cancer	6.19e-06	6.42e-05	CcSEcCtD
Progesterone—Muscle spasms—Doxorubicin—prostate cancer	6.18e-06	6.41e-05	CcSEcCtD
Progesterone—Palpitations—Epirubicin—prostate cancer	6.13e-06	6.37e-05	CcSEcCtD
Progesterone—Loss of consciousness—Epirubicin—prostate cancer	6.1e-06	6.33e-05	CcSEcCtD
Progesterone—Cough—Epirubicin—prostate cancer	6.06e-06	6.29e-05	CcSEcCtD
Progesterone—Vision blurred—Doxorubicin—prostate cancer	6.05e-06	6.28e-05	CcSEcCtD
Progesterone—Asthenia—Docetaxel—prostate cancer	6.03e-06	6.26e-05	CcSEcCtD
Progesterone—Convulsion—Epirubicin—prostate cancer	6.01e-06	6.24e-05	CcSEcCtD
Progesterone—Nausea—Etoposide—prostate cancer	6e-06	6.23e-05	CcSEcCtD
Progesterone—Hypertension—Epirubicin—prostate cancer	5.99e-06	6.22e-05	CcSEcCtD
Progesterone—Hypersensitivity—Capecitabine—prostate cancer	5.99e-06	6.22e-05	CcSEcCtD
Progesterone—Feeling abnormal—Prednisone—prostate cancer	5.97e-06	6.2e-05	CcSEcCtD
Progesterone—Ill-defined disorder—Doxorubicin—prostate cancer	5.96e-06	6.19e-05	CcSEcCtD
Progesterone—Pruritus—Docetaxel—prostate cancer	5.94e-06	6.17e-05	CcSEcCtD
Progesterone—Anaemia—Doxorubicin—prostate cancer	5.94e-06	6.16e-05	CcSEcCtD
Progesterone—Gastrointestinal pain—Prednisone—prostate cancer	5.92e-06	6.15e-05	CcSEcCtD
Progesterone—Arthralgia—Epirubicin—prostate cancer	5.91e-06	6.14e-05	CcSEcCtD
Progesterone—Myalgia—Epirubicin—prostate cancer	5.91e-06	6.14e-05	CcSEcCtD
Progesterone—Chest pain—Epirubicin—prostate cancer	5.91e-06	6.14e-05	CcSEcCtD
Progesterone—Anxiety—Epirubicin—prostate cancer	5.89e-06	6.11e-05	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	5.87e-06	6.09e-05	CcSEcCtD
Progesterone—Discomfort—Epirubicin—prostate cancer	5.84e-06	6.06e-05	CcSEcCtD
Progesterone—Asthenia—Capecitabine—prostate cancer	5.84e-06	6.06e-05	CcSEcCtD
Progesterone—Malaise—Doxorubicin—prostate cancer	5.79e-06	6.01e-05	CcSEcCtD
Progesterone—Dry mouth—Epirubicin—prostate cancer	5.78e-06	6e-05	CcSEcCtD
Progesterone—Vertigo—Doxorubicin—prostate cancer	5.77e-06	5.99e-05	CcSEcCtD
Progesterone—Syncope—Doxorubicin—prostate cancer	5.76e-06	5.98e-05	CcSEcCtD
Progesterone—Urticaria—Prednisone—prostate cancer	5.75e-06	5.97e-05	CcSEcCtD
Progesterone—Pruritus—Capecitabine—prostate cancer	5.75e-06	5.97e-05	CcSEcCtD
Progesterone—Diarrhoea—Docetaxel—prostate cancer	5.75e-06	5.97e-05	CcSEcCtD
Progesterone—Abdominal pain—Prednisone—prostate cancer	5.73e-06	5.95e-05	CcSEcCtD
Progesterone—Body temperature increased—Prednisone—prostate cancer	5.73e-06	5.95e-05	CcSEcCtD
Progesterone—Confusional state—Epirubicin—prostate cancer	5.71e-06	5.93e-05	CcSEcCtD
Progesterone—Palpitations—Doxorubicin—prostate cancer	5.68e-06	5.89e-05	CcSEcCtD
Progesterone—Oedema—Epirubicin—prostate cancer	5.67e-06	5.88e-05	CcSEcCtD
Progesterone—Anaphylactic shock—Epirubicin—prostate cancer	5.67e-06	5.88e-05	CcSEcCtD
Progesterone—Loss of consciousness—Doxorubicin—prostate cancer	5.65e-06	5.86e-05	CcSEcCtD
Progesterone—Infection—Epirubicin—prostate cancer	5.63e-06	5.84e-05	CcSEcCtD
Progesterone—Cough—Doxorubicin—prostate cancer	5.61e-06	5.82e-05	CcSEcCtD
Progesterone—Shock—Epirubicin—prostate cancer	5.57e-06	5.79e-05	CcSEcCtD
Progesterone—Convulsion—Doxorubicin—prostate cancer	5.57e-06	5.78e-05	CcSEcCtD
Progesterone—Diarrhoea—Capecitabine—prostate cancer	5.56e-06	5.78e-05	CcSEcCtD
Progesterone—Nervous system disorder—Epirubicin—prostate cancer	5.56e-06	5.77e-05	CcSEcCtD
Progesterone—Dizziness—Docetaxel—prostate cancer	5.55e-06	5.77e-05	CcSEcCtD
Progesterone—Hypertension—Doxorubicin—prostate cancer	5.55e-06	5.76e-05	CcSEcCtD
Progesterone—Tachycardia—Epirubicin—prostate cancer	5.53e-06	5.74e-05	CcSEcCtD
Progesterone—Skin disorder—Epirubicin—prostate cancer	5.5e-06	5.71e-05	CcSEcCtD
Progesterone—Hyperhidrosis—Epirubicin—prostate cancer	5.48e-06	5.69e-05	CcSEcCtD
Progesterone—Arthralgia—Doxorubicin—prostate cancer	5.47e-06	5.68e-05	CcSEcCtD
Progesterone—Chest pain—Doxorubicin—prostate cancer	5.47e-06	5.68e-05	CcSEcCtD
Progesterone—Myalgia—Doxorubicin—prostate cancer	5.47e-06	5.68e-05	CcSEcCtD
Progesterone—Anxiety—Doxorubicin—prostate cancer	5.45e-06	5.66e-05	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	5.43e-06	5.64e-05	CcSEcCtD
Progesterone—Discomfort—Doxorubicin—prostate cancer	5.4e-06	5.61e-05	CcSEcCtD
Progesterone—Anorexia—Epirubicin—prostate cancer	5.4e-06	5.61e-05	CcSEcCtD
Progesterone—Dizziness—Capecitabine—prostate cancer	5.38e-06	5.58e-05	CcSEcCtD
Progesterone—Dry mouth—Doxorubicin—prostate cancer	5.35e-06	5.55e-05	CcSEcCtD
Progesterone—Vomiting—Docetaxel—prostate cancer	5.34e-06	5.54e-05	CcSEcCtD
Progesterone—Hypersensitivity—Prednisone—prostate cancer	5.34e-06	5.54e-05	CcSEcCtD
Progesterone—Rash—Docetaxel—prostate cancer	5.3e-06	5.5e-05	CcSEcCtD
Progesterone—Hypotension—Epirubicin—prostate cancer	5.29e-06	5.5e-05	CcSEcCtD
Progesterone—Hydrocortisone—CYP3A4—prostate cancer	5.29e-06	0.00204	CrCbGaD
Progesterone—Dermatitis—Docetaxel—prostate cancer	5.29e-06	5.49e-05	CcSEcCtD
Progesterone—Confusional state—Doxorubicin—prostate cancer	5.29e-06	5.49e-05	CcSEcCtD
Progesterone—Headache—Docetaxel—prostate cancer	5.26e-06	5.46e-05	CcSEcCtD
Progesterone—Anaphylactic shock—Doxorubicin—prostate cancer	5.24e-06	5.44e-05	CcSEcCtD
Progesterone—Oedema—Doxorubicin—prostate cancer	5.24e-06	5.44e-05	CcSEcCtD
Progesterone—Infection—Doxorubicin—prostate cancer	5.21e-06	5.41e-05	CcSEcCtD
Progesterone—Asthenia—Prednisone—prostate cancer	5.2e-06	5.4e-05	CcSEcCtD
Progesterone—Vomiting—Capecitabine—prostate cancer	5.17e-06	5.37e-05	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.16e-06	5.36e-05	CcSEcCtD
Progesterone—Shock—Doxorubicin—prostate cancer	5.16e-06	5.35e-05	CcSEcCtD
Progesterone—Nervous system disorder—Doxorubicin—prostate cancer	5.14e-06	5.34e-05	CcSEcCtD
Progesterone—Rash—Capecitabine—prostate cancer	5.13e-06	5.32e-05	CcSEcCtD
Progesterone—Pruritus—Prednisone—prostate cancer	5.13e-06	5.32e-05	CcSEcCtD
Progesterone—Insomnia—Epirubicin—prostate cancer	5.12e-06	5.32e-05	CcSEcCtD
Progesterone—Dermatitis—Capecitabine—prostate cancer	5.12e-06	5.32e-05	CcSEcCtD
Progesterone—Tachycardia—Doxorubicin—prostate cancer	5.12e-06	5.31e-05	CcSEcCtD
Progesterone—Headache—Capecitabine—prostate cancer	5.09e-06	5.29e-05	CcSEcCtD
Progesterone—Skin disorder—Doxorubicin—prostate cancer	5.09e-06	5.29e-05	CcSEcCtD
Progesterone—Paraesthesia—Epirubicin—prostate cancer	5.09e-06	5.28e-05	CcSEcCtD
Progesterone—Hyperhidrosis—Doxorubicin—prostate cancer	5.07e-06	5.26e-05	CcSEcCtD
Progesterone—Dyspnoea—Epirubicin—prostate cancer	5.05e-06	5.24e-05	CcSEcCtD
Progesterone—Somnolence—Epirubicin—prostate cancer	5.04e-06	5.23e-05	CcSEcCtD
Progesterone—Anorexia—Doxorubicin—prostate cancer	5e-06	5.19e-05	CcSEcCtD
Progesterone—Nausea—Docetaxel—prostate cancer	4.99e-06	5.18e-05	CcSEcCtD
Progesterone—Dyspepsia—Epirubicin—prostate cancer	4.99e-06	5.18e-05	CcSEcCtD
Progesterone—Diarrhoea—Prednisone—prostate cancer	4.96e-06	5.15e-05	CcSEcCtD
Progesterone—Decreased appetite—Epirubicin—prostate cancer	4.93e-06	5.11e-05	CcSEcCtD
Progesterone—Hypotension—Doxorubicin—prostate cancer	4.9e-06	5.09e-05	CcSEcCtD
Progesterone—Gastrointestinal disorder—Epirubicin—prostate cancer	4.89e-06	5.08e-05	CcSEcCtD
Progesterone—Fatigue—Epirubicin—prostate cancer	4.88e-06	5.07e-05	CcSEcCtD
Progesterone—Pain—Epirubicin—prostate cancer	4.85e-06	5.03e-05	CcSEcCtD
Progesterone—Constipation—Epirubicin—prostate cancer	4.85e-06	5.03e-05	CcSEcCtD
Progesterone—Nausea—Capecitabine—prostate cancer	4.83e-06	5.01e-05	CcSEcCtD
Progesterone—Dizziness—Prednisone—prostate cancer	4.79e-06	4.97e-05	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	4.78e-06	4.96e-05	CcSEcCtD
Progesterone—Insomnia—Doxorubicin—prostate cancer	4.74e-06	4.92e-05	CcSEcCtD
Progesterone—Paraesthesia—Doxorubicin—prostate cancer	4.71e-06	4.89e-05	CcSEcCtD
Progesterone—Dyspnoea—Doxorubicin—prostate cancer	4.67e-06	4.85e-05	CcSEcCtD
Progesterone—Feeling abnormal—Epirubicin—prostate cancer	4.67e-06	4.85e-05	CcSEcCtD
Progesterone—Somnolence—Doxorubicin—prostate cancer	4.66e-06	4.84e-05	CcSEcCtD
Progesterone—Gastrointestinal pain—Epirubicin—prostate cancer	4.63e-06	4.81e-05	CcSEcCtD
Progesterone—Dyspepsia—Doxorubicin—prostate cancer	4.61e-06	4.79e-05	CcSEcCtD
Progesterone—Vomiting—Prednisone—prostate cancer	4.61e-06	4.78e-05	CcSEcCtD
Progesterone—Rash—Prednisone—prostate cancer	4.57e-06	4.74e-05	CcSEcCtD
Progesterone—Dermatitis—Prednisone—prostate cancer	4.56e-06	4.74e-05	CcSEcCtD
Progesterone—Decreased appetite—Doxorubicin—prostate cancer	4.56e-06	4.73e-05	CcSEcCtD
Progesterone—Headache—Prednisone—prostate cancer	4.54e-06	4.71e-05	CcSEcCtD
Progesterone—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.53e-06	4.7e-05	CcSEcCtD
Progesterone—Fatigue—Doxorubicin—prostate cancer	4.52e-06	4.69e-05	CcSEcCtD
Progesterone—Urticaria—Epirubicin—prostate cancer	4.5e-06	4.67e-05	CcSEcCtD
Progesterone—Pain—Doxorubicin—prostate cancer	4.48e-06	4.65e-05	CcSEcCtD
Progesterone—Constipation—Doxorubicin—prostate cancer	4.48e-06	4.65e-05	CcSEcCtD
Progesterone—Abdominal pain—Epirubicin—prostate cancer	4.48e-06	4.65e-05	CcSEcCtD
Progesterone—Body temperature increased—Epirubicin—prostate cancer	4.48e-06	4.65e-05	CcSEcCtD
Progesterone—Feeling abnormal—Doxorubicin—prostate cancer	4.32e-06	4.48e-05	CcSEcCtD
Progesterone—Nausea—Prednisone—prostate cancer	4.3e-06	4.47e-05	CcSEcCtD
Progesterone—Gastrointestinal pain—Doxorubicin—prostate cancer	4.29e-06	4.45e-05	CcSEcCtD
Progesterone—Hypersensitivity—Epirubicin—prostate cancer	4.17e-06	4.33e-05	CcSEcCtD
Progesterone—Urticaria—Doxorubicin—prostate cancer	4.16e-06	4.32e-05	CcSEcCtD
Progesterone—Body temperature increased—Doxorubicin—prostate cancer	4.14e-06	4.3e-05	CcSEcCtD
Progesterone—Abdominal pain—Doxorubicin—prostate cancer	4.14e-06	4.3e-05	CcSEcCtD
Progesterone—Testosterone—CYP3A4—prostate cancer	4.08e-06	0.00157	CrCbGaD
Progesterone—Asthenia—Epirubicin—prostate cancer	4.07e-06	4.22e-05	CcSEcCtD
Progesterone—Pruritus—Epirubicin—prostate cancer	4.01e-06	4.16e-05	CcSEcCtD
Progesterone—Diarrhoea—Epirubicin—prostate cancer	3.88e-06	4.02e-05	CcSEcCtD
Progesterone—Hypersensitivity—Doxorubicin—prostate cancer	3.86e-06	4.01e-05	CcSEcCtD
Progesterone—Asthenia—Doxorubicin—prostate cancer	3.76e-06	3.9e-05	CcSEcCtD
Progesterone—Dizziness—Epirubicin—prostate cancer	3.75e-06	3.89e-05	CcSEcCtD
Progesterone—Pruritus—Doxorubicin—prostate cancer	3.71e-06	3.85e-05	CcSEcCtD
Progesterone—Vomiting—Epirubicin—prostate cancer	3.6e-06	3.74e-05	CcSEcCtD
Progesterone—Diarrhoea—Doxorubicin—prostate cancer	3.59e-06	3.72e-05	CcSEcCtD
Progesterone—Rash—Epirubicin—prostate cancer	3.57e-06	3.71e-05	CcSEcCtD
Progesterone—Dermatitis—Epirubicin—prostate cancer	3.57e-06	3.71e-05	CcSEcCtD
Progesterone—Headache—Epirubicin—prostate cancer	3.55e-06	3.68e-05	CcSEcCtD
Progesterone—Dizziness—Doxorubicin—prostate cancer	3.47e-06	3.6e-05	CcSEcCtD
Progesterone—Nausea—Epirubicin—prostate cancer	3.37e-06	3.49e-05	CcSEcCtD
Progesterone—Vomiting—Doxorubicin—prostate cancer	3.33e-06	3.46e-05	CcSEcCtD
Progesterone—Rash—Doxorubicin—prostate cancer	3.31e-06	3.43e-05	CcSEcCtD
Progesterone—Dermatitis—Doxorubicin—prostate cancer	3.3e-06	3.43e-05	CcSEcCtD
Progesterone—Headache—Doxorubicin—prostate cancer	3.28e-06	3.41e-05	CcSEcCtD
Progesterone—Nausea—Doxorubicin—prostate cancer	3.11e-06	3.23e-05	CcSEcCtD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.25e-07	6.97e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NOS3—prostate cancer	4.25e-07	6.96e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CYP1A1—prostate cancer	4.23e-07	6.94e-06	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CB—prostate cancer	4.23e-07	6.94e-06	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PIK3CA—prostate cancer	4.23e-07	6.94e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ACHE—prostate cancer	4.22e-07	6.91e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSTT1—prostate cancer	4.22e-07	6.91e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GGT1—prostate cancer	4.22e-07	6.91e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ERCC2—prostate cancer	4.2e-07	6.89e-06	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTGS2—prostate cancer	4.19e-07	6.88e-06	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—SRC—prostate cancer	4.19e-07	6.87e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP2A6—prostate cancer	4.17e-07	6.83e-06	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CB—prostate cancer	4.17e-07	6.83e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—TYMS—prostate cancer	4.16e-07	6.81e-06	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—EP300—prostate cancer	4.16e-07	6.81e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—NCOA1—prostate cancer	4.15e-07	6.81e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CYP1A1—prostate cancer	4.13e-07	6.78e-06	CbGpPWpGaD
Progesterone—ABCC1—Disease—KRAS—prostate cancer	4.13e-07	6.77e-06	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTGS2—prostate cancer	4.13e-07	6.77e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—JAK2—prostate cancer	4.13e-07	6.77e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—TYMS—prostate cancer	4.12e-07	6.76e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GSTM1—prostate cancer	4.11e-07	6.74e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—ERCC2—prostate cancer	4.1e-07	6.72e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CYP19A1—prostate cancer	4.09e-07	6.71e-06	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—VEGFA—prostate cancer	4.08e-07	6.69e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CAV1—prostate cancer	4.08e-07	6.69e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GSTM1—prostate cancer	4.07e-07	6.68e-06	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PIK3CA—prostate cancer	4.07e-07	6.68e-06	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—INS—prostate cancer	4.06e-07	6.66e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—AKR1C3—prostate cancer	4.05e-07	6.65e-06	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CG—prostate cancer	4.05e-07	6.65e-06	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—STAT3—prostate cancer	4.04e-07	6.63e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PRKACB—prostate cancer	4.03e-07	6.61e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—LPL—prostate cancer	4.03e-07	6.61e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MDM2—prostate cancer	4.03e-07	6.61e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—LPL—prostate cancer	4e-07	6.55e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.99e-07	6.54e-06	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—CREBBP—prostate cancer	3.98e-07	6.52e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—ERBB2—prostate cancer	3.97e-07	6.51e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—RXRA—prostate cancer	3.95e-07	6.48e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—MTHFR—prostate cancer	3.95e-07	6.47e-06	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—prostate cancer	3.94e-07	6.46e-06	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PTEN—prostate cancer	3.93e-07	6.44e-06	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PTEN—prostate cancer	3.92e-07	6.43e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CB—prostate cancer	3.92e-07	6.43e-06	CbGpPWpGaD
Progesterone—AR—Gene Expression—AKT1—prostate cancer	3.9e-07	6.39e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.9e-07	6.39e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CYP1A1—prostate cancer	3.89e-07	6.39e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PPARA—prostate cancer	3.87e-07	6.35e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ERCC2—prostate cancer	3.86e-07	6.33e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CYP1A1—prostate cancer	3.86e-07	6.33e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—MTHFR—prostate cancer	3.85e-07	6.32e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.84e-07	6.3e-06	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—INS—prostate cancer	3.84e-07	6.29e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ERCC2—prostate cancer	3.83e-07	6.28e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—COMT—prostate cancer	3.81e-07	6.24e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—NCOA2—prostate cancer	3.8e-07	6.24e-06	CbGpPWpGaD
Progesterone—ABCC1—Disease—PIK3CA—prostate cancer	3.8e-07	6.22e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GSTP1—prostate cancer	3.79e-07	6.21e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PPARA—prostate cancer	3.78e-07	6.2e-06	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CD—prostate cancer	3.77e-07	6.18e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CXCL8—prostate cancer	3.77e-07	6.18e-06	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—CREBBP—prostate cancer	3.76e-07	6.16e-06	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MYC—prostate cancer	3.76e-07	6.16e-06	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—EP300—prostate cancer	3.75e-07	6.14e-06	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TGFB1—prostate cancer	3.75e-07	6.14e-06	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—EP300—prostate cancer	3.74e-07	6.13e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ITPR1—prostate cancer	3.73e-07	6.11e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CG—prostate cancer	3.72e-07	6.09e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CDKN1B—prostate cancer	3.68e-07	6.03e-06	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—EGFR—prostate cancer	3.67e-07	6.02e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.66e-07	6.01e-06	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTEN—prostate cancer	3.66e-07	6e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CAV1—prostate cancer	3.64e-07	5.97e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—MTHFR—prostate cancer	3.63e-07	5.95e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.63e-07	5.95e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CASP3—prostate cancer	3.61e-07	5.91e-06	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—IL6—prostate cancer	3.61e-07	5.91e-06	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—AKT1—prostate cancer	3.61e-07	5.91e-06	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTEN—prostate cancer	3.6e-07	5.91e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL2—prostate cancer	3.6e-07	5.9e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—MTHFR—prostate cancer	3.6e-07	5.9e-06	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CD—prostate cancer	3.56e-07	5.84e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PPARA—prostate cancer	3.56e-07	5.84e-06	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—NOS3—prostate cancer	3.56e-07	5.84e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CAV1—prostate cancer	3.55e-07	5.83e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.54e-07	5.81e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PPARA—prostate cancer	3.53e-07	5.79e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—TYMS—prostate cancer	3.52e-07	5.77e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—INS—prostate cancer	3.52e-07	5.77e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CCND1—prostate cancer	3.51e-07	5.75e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—NQO1—prostate cancer	3.5e-07	5.75e-06	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—EP300—prostate cancer	3.49e-07	5.72e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GSTM1—prostate cancer	3.48e-07	5.71e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.48e-07	5.7e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CTNNB1—prostate cancer	3.48e-07	5.7e-06	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—KRAS—prostate cancer	3.47e-07	5.69e-06	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—AKT1—prostate cancer	3.46e-07	5.67e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—TH—prostate cancer	3.45e-07	5.66e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CREBBP—prostate cancer	3.45e-07	5.65e-06	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—EP300—prostate cancer	3.43e-07	5.63e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—LPL—prostate cancer	3.42e-07	5.6e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MMP9—prostate cancer	3.41e-07	5.59e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CDKN1A—prostate cancer	3.4e-07	5.57e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PTEN—prostate cancer	3.39e-07	5.55e-06	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—NOS3—prostate cancer	3.36e-07	5.52e-06	CbGpPWpGaD
Progesterone—ABCC1—Disease—IL6—prostate cancer	3.36e-07	5.51e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.36e-07	5.51e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CAV1—prostate cancer	3.35e-07	5.49e-06	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—AKT1—prostate cancer	3.33e-07	5.45e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CAV1—prostate cancer	3.32e-07	5.44e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CG—prostate cancer	3.32e-07	5.44e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CYP1A1—prostate cancer	3.3e-07	5.41e-06	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CB—prostate cancer	3.29e-07	5.39e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ERCC2—prostate cancer	3.27e-07	5.36e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CD—prostate cancer	3.27e-07	5.36e-06	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTGS2—prostate cancer	3.26e-07	5.34e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GGT1—prostate cancer	3.25e-07	5.34e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CG—prostate cancer	3.24e-07	5.31e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EP300—prostate cancer	3.23e-07	5.3e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—NCOA1—prostate cancer	3.21e-07	5.26e-06	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PIK3CA—prostate cancer	3.19e-07	5.23e-06	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PIK3CA—prostate cancer	3.18e-07	5.21e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.17e-07	5.2e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.16e-07	5.18e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—SRC—prostate cancer	3.14e-07	5.15e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—INS—prostate cancer	3.14e-07	5.15e-06	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CB—prostate cancer	3.11e-07	5.09e-06	CbGpPWpGaD
Progesterone—ABCC1—Disease—AKT1—prostate cancer	3.1e-07	5.08e-06	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—prostate cancer	3.09e-07	5.06e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—NOS3—prostate cancer	3.08e-07	5.06e-06	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTGS2—prostate cancer	3.08e-07	5.05e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—MTHFR—prostate cancer	3.08e-07	5.04e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CREBBP—prostate cancer	3.07e-07	5.04e-06	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PIK3CA—prostate cancer	3.07e-07	5.04e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—INS—prostate cancer	3.06e-07	5.02e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—VEGFA—prostate cancer	3.06e-07	5.02e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CG—prostate cancer	3.05e-07	5e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—RXRA—prostate cancer	3.05e-07	5e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—STAT3—prostate cancer	3.03e-07	4.97e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CG—prostate cancer	3.02e-07	4.96e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PPARA—prostate cancer	3.02e-07	4.95e-06	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—AKT1—prostate cancer	3e-07	4.92e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CREBBP—prostate cancer	3e-07	4.92e-06	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—AKT1—prostate cancer	2.96e-07	4.85e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—COMT—prostate cancer	2.94e-07	4.81e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSTP1—prostate cancer	2.92e-07	4.79e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CD—prostate cancer	2.92e-07	4.78e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—INS—prostate cancer	2.89e-07	4.73e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ITPR1—prostate cancer	2.88e-07	4.72e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—INS—prostate cancer	2.86e-07	4.69e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CB—prostate cancer	2.85e-07	4.67e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CD—prostate cancer	2.85e-07	4.67e-06	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTEN—prostate cancer	2.84e-07	4.66e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CAV1—prostate cancer	2.84e-07	4.65e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CREBBP—prostate cancer	2.83e-07	4.64e-06	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IL6—prostate cancer	2.82e-07	4.63e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTGS2—prostate cancer	2.82e-07	4.63e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MYC—prostate cancer	2.82e-07	4.62e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TGFB1—prostate cancer	2.81e-07	4.6e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CREBBP—prostate cancer	2.8e-07	4.6e-06	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CA—prostate cancer	2.77e-07	4.55e-06	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CA—prostate cancer	2.77e-07	4.54e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EGFR—prostate cancer	2.75e-07	4.51e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—NOS3—prostate cancer	2.75e-07	4.51e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—TYMS—prostate cancer	2.72e-07	4.46e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.71e-07	4.44e-06	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—EP300—prostate cancer	2.71e-07	4.44e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—NOS3—prostate cancer	2.69e-07	4.41e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSTM1—prostate cancer	2.69e-07	4.4e-06	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTEN—prostate cancer	2.68e-07	4.4e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.68e-07	4.4e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CD—prostate cancer	2.66e-07	4.36e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—LPL—prostate cancer	2.64e-07	4.32e-06	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—AKT1—prostate cancer	2.61e-07	4.27e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KRAS—prostate cancer	2.6e-07	4.26e-06	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—AKT1—prostate cancer	2.6e-07	4.26e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CG—prostate cancer	2.58e-07	4.24e-06	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CA—prostate cancer	2.58e-07	4.23e-06	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—EP300—prostate cancer	2.56e-07	4.2e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.55e-07	4.17e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CB—prostate cancer	2.54e-07	4.17e-06	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CA—prostate cancer	2.54e-07	4.17e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—NOS3—prostate cancer	2.53e-07	4.15e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ERCC2—prostate cancer	2.53e-07	4.14e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTGS2—prostate cancer	2.52e-07	4.13e-06	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—AKT1—prostate cancer	2.51e-07	4.12e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—NOS3—prostate cancer	2.51e-07	4.12e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CB—prostate cancer	2.48e-07	4.07e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTEN—prostate cancer	2.46e-07	4.03e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTGS2—prostate cancer	2.46e-07	4.03e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—INS—prostate cancer	2.45e-07	4.01e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CREBBP—prostate cancer	2.4e-07	3.93e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CA—prostate cancer	2.39e-07	3.92e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—MTHFR—prostate cancer	2.37e-07	3.89e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—EP300—prostate cancer	2.35e-07	3.85e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CB—prostate cancer	2.34e-07	3.83e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PPARA—prostate cancer	2.33e-07	3.82e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CB—prostate cancer	2.32e-07	3.8e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTGS2—prostate cancer	2.32e-07	3.8e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—prostate cancer	2.31e-07	3.79e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTGS2—prostate cancer	2.3e-07	3.76e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CD—prostate cancer	2.27e-07	3.72e-06	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—AKT1—prostate cancer	2.26e-07	3.71e-06	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—AKT1—prostate cancer	2.26e-07	3.71e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTEN—prostate cancer	2.2e-07	3.6e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CAV1—prostate cancer	2.19e-07	3.59e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—NOS3—prostate cancer	2.15e-07	3.52e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTEN—prostate cancer	2.14e-07	3.51e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL6—prostate cancer	2.12e-07	3.47e-06	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—AKT1—prostate cancer	2.11e-07	3.46e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—EP300—prostate cancer	2.09e-07	3.43e-06	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—AKT1—prostate cancer	2.08e-07	3.4e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—EP300—prostate cancer	2.04e-07	3.35e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTEN—prostate cancer	2.02e-07	3.31e-06	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CA—prostate cancer	2e-07	3.29e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTEN—prostate cancer	2e-07	3.28e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.99e-07	3.27e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.98e-07	3.25e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTGS2—prostate cancer	1.96e-07	3.22e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—AKT1—prostate cancer	1.95e-07	3.2e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—EP300—prostate cancer	1.93e-07	3.16e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—EP300—prostate cancer	1.91e-07	3.13e-06	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CA—prostate cancer	1.89e-07	3.1e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—INS—prostate cancer	1.89e-07	3.1e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CREBBP—prostate cancer	1.85e-07	3.03e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.75e-07	2.87e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CA—prostate cancer	1.74e-07	2.85e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTEN—prostate cancer	1.71e-07	2.81e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—NOS3—prostate cancer	1.66e-07	2.71e-06	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—AKT1—prostate cancer	1.64e-07	2.68e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—EP300—prostate cancer	1.63e-07	2.68e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.55e-07	2.54e-06	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—AKT1—prostate cancer	1.55e-07	2.54e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.53e-07	2.51e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTGS2—prostate cancer	1.51e-07	2.48e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CA—prostate cancer	1.51e-07	2.48e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.42e-07	2.34e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—AKT1—prostate cancer	1.42e-07	2.32e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CA—prostate cancer	1.41e-07	2.32e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTEN—prostate cancer	1.32e-07	2.17e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—AKT1—prostate cancer	1.27e-07	2.07e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—EP300—prostate cancer	1.26e-07	2.06e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—AKT1—prostate cancer	1.24e-07	2.03e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.21e-07	1.98e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—AKT1—prostate cancer	1.16e-07	1.91e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—AKT1—prostate cancer	1.15e-07	1.89e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—AKT1—prostate cancer	9.86e-08	1.62e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CA—prostate cancer	9.32e-08	1.53e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—AKT1—prostate cancer	7.61e-08	1.25e-06	CbGpPWpGaD
